NCT04097405View on ClinicalTrials.gov

Phase I Study of D-0120 to Evaluate Safety and PK/PD Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 18, 2019

Primary Completion Date

March 30, 2020

Study Completion Date

November 18, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

D-0120

Randomized, Double-Blind, Placebo-Controlled, Multiple Dose and Dose Escalation of D-0120 or Placebo

DRUG

Placebo oral tablet

Randomized, Double-Blind, Placebo-Controlled, Multiple Dose and Dose Escalation of D-0120 or Placebo

Trial Locations (1)

33163

Syneos Health, Miami

Sponsors
All Listed Sponsors
lead

InventisBio Co., Ltd

INDUSTRY